Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

ClinicalTrials.gov ID: NCT00046930

Public ClinicalTrials.gov record NCT00046930. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double Blind, Trial of the Administration of the MDR Modulator, Zosuquidar Trihydrochloride (LY335979), During Conventional Induction and Post-Remission Therapy in Patients Greater Than 60 Years of Age With Newly Diagnosed Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation or High-Risk Refractory Anemia With Excess Blasts

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Zosuquidar trihydrochloride, a modulator of multidrug resistance (MDR), may help daunorubicin and cytarabine kill more cancer cells by making cancer cells more sensitive to the drugs. It is not yet known whether daunorubicin and cytarabine are more effective with or without zosuquidar trihydrochloride in treating acute myeloid leukemia or anemia. PURPOSE: This randomized phase III trial is studying how well giving zosuquidar trihydrochloride together with daunorubicin and cytarabine works compared to daunorubicin and cytarabine alone in treating older patients with newly diagnosed acute myeloid leukemia or anemia that has not responded to previous treatment.

Study identification

NCT ID
NCT00046930
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
449 participants

Conditions and interventions

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 17, 2002 (Actual)
Primary completion
Jun 2009 (Actual)
Completion
Not listed
Last update posted
Jul 5, 2023

Started 2002

United States locations

U.S. sites
91
U.S. states
21
U.S. cities
70
Facility City State ZIP Site status
CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale Arizona 85259 —
Aurora Presbyterian Hospital Aurora Colorado 80012 —
Boulder Community Hospital Boulder Colorado 80301 —
Penrose Cancer Center at Penrose Hospital Colorado Springs Colorado 80933 —
Porter Adventist Hospital Denver Colorado 80210 —
Presbyterian - St. Luke's Medical Center Denver Colorado 80218 —
St. Joseph Hospital Denver Colorado 80218 —
Rose Medical Center Denver Colorado 80220 —
CCOP - Colorado Cancer Research Program, Incorporated Denver Colorado 80224-2522 —
Swedish Medical Center Englewood Colorado 80110 —
Sky Ridge Medical Center Lone Tree Colorado 80124 —
Hope Cancer Care Center at Longmont United Hospital Longmont Colorado 80502 —
St. Mary-Corwin Regional Medical Center Pueblo Colorado 81004 —
North Suburban Medical Center Thornton Colorado 80229 —
University of Florida Shands Cancer Center Gainesville Florida 32610 —
Baptist Cancer Institute - Jacksonville Jacksonville Florida 32207 —
Mayo Clinic - Jacksonville Jacksonville Florida 32224-9980 —
Watson Clinic, LLC Lakeland Florida 33805 —
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa Florida 33612 —
MBCCOP-Medical College of Georgia Cancer Center Augusta Georgia 30912 —
Hematology and Oncology Associates Chicago Illinois 60611 —
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526 —
Evanston Northwestern Health Care - Evanston Hospital Evanston Illinois 60201 —
Regional Cancer Center at Memorial Medical Center Springfield Illinois 62781-0001 —
Carle Cancer Center at Carle Foundation Hospital Urbana Illinois 61801 —
Indiana University Cancer Center Indianapolis Indiana 46202 —
Methodist Cancer Center at Methodist Hospital Indianapolis Indiana 46202 —
McFarland Clinic, P.C. Ames Iowa 50010 —
Siouxland Hematology-Oncology Associates Sioux City Iowa 51101 —
St. Luke's Regional Medical Center Sioux City Iowa 51104 —
Cancer Center of Kansas - Chanute Chanute Kansas 66720 —
Cancer Center of Kansas - Dodge City Dodge City Kansas 67801 —
Cancer Center of Kansas - Kingman Kingman Kansas 67068 —
Southwest Medical Center Liberal Kansas 67901 —
Cancer Center of Kansas - Newton Newton Kansas 67114 —
Pratt Cancer Center of Kansas Pratt Kansas 67124 —
Cancer Center of Kansas - Salina Salina Kansas 67042 —
Cancer Center of Kansas - Wellington Wellington Kansas 67152 —
Associates in Womens Health Wichita Kansas 67203 —
Cancer Center of Kansas, P.A. Wichita Kansas 67208 —
Cancer Center of Kansas, P.A. - Wichita Wichita Kansas 67214 —
CCOP - Wichita Wichita Kansas 67214 —
Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas 67214 —
Wesley Medical Center Wichita Kansas 67214 —
Cancer Center of Kansas - Winfield Winfield Kansas 67156 —
Tufts - New England Medical Center Boston Massachusetts 02111 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Baystate Regional Cancer Program at D'Amour Center for Cancer Care Springfield Massachusetts 01199 —
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48100 —
St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital Ann Arbor Michigan 48106-0995 —
Borgess Medical Center Kalamazoo Michigan 49001 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Fairview Ridges Hospital Burnsville Minnesota 55337 —
Mercy and Unity Cancer Center at Mercy Hospital Coon Rapids Minnesota 55433 —
Fairview Southdale Hospital Edina Minnesota 55435 —
Mercy and Unity Cancer Center at Unity Hospital Fridley Minnesota 55432 —
Virginia Piper Cancer Institute at Abbott-Northwestern Hospital Minneapolis Minnesota 55403 —
Hubert H. Humphrey Cancer Center at North Memorial Medical Center Robbinsdale Minnesota 55422 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
Park Nicollet Clinic Saint Louis Park Minnesota 55416 —
United Hospital Saint Paul Minnesota 55102 —
Ridgeview Medical Center Waconia Minnesota 55387 —
University Medical Center of Southern Nevada Las Vegas Nevada 89102 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
CCOP - Northern New Jersey Hackensack New Jersey 07601 —
Booker Cancer Center at Riverview Medical Center Red Bank New Jersey 07701 —
NYU Cancer Institute at New York University Medical Center New York New York 10016 —
Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx New York 10461 —
Leo W. Jenkins Cancer Center at Pitt County Memorial Hospital Greenville North Carolina 27858 —
Aultman Hospital Cancer Center at Aultman Health Foundation Canton Ohio 44710 —
Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland Ohio 44106 —
MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland Ohio 44109 —
St. Luke's Hospital Cancer Center Bethlehem Pennsylvania 18015 —
Geisinger Medical Center Danville Pennsylvania 17822-2001 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15213 —
Guthrie Medical Center - Sayre Sayre Pennsylvania 18840 —
Hematology and Oncology Associates Scranton Pennsylvania 18510 —
Geisinger Medical Group State College Pennsylvania 16801 —
Geisinger Wyoming Valley Medical Center Wilkes-Barre Pennsylvania 18711 —
Sioux Valley Hospital and University of South Dakota Medical Center Sioux Falls South Dakota 57104 —
University of Virginia Cancer Center Charlottesville Virginia 22908 —
Mary Babb Randolph Cancer Center at West Virginia University Hospitals Morgantown West Virginia 26506 —
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601 —
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792 —
Marshfield Clinic - Marshfield Center Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00046930, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00046930 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →